Singapore markets closed
Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,477.15 +211.23 (+0.33%) CMC Crypto 200
1,350.71 -9.62 (-0.71%)
Genscript Biotech Corporation (1548.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 18.05B |
| Enterprise value | 6.25B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.73 |
| Price/book (mrq) | 1.66 |
| Enterprise value/revenue | 0.95 |
| Enterprise value/EBITDA | -60.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.00 |
| 52-week change 3 | -55.03% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 24.950 |
| 52-week low 3 | 7.430 |
| 50-day moving average 3 | 10.844 |
| 200-day moving average 3 | 16.534 |
Share statistics
| Avg vol (3-month) 3 | 16.29M |
| Avg vol (10-day) 3 | 13.38M |
| Shares outstanding 5 | 2.13B |
| Implied shares outstanding 6 | 2.13B |
| Float 8 | 1.16B |
| % held by insiders 1 | 37.78% |
| % held by institutions 1 | 26.86% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 05 Jun 2017 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -11.37% |
| Operating margin (ttm) | -43.11% |
Management effectiveness
| Return on assets (ttm) | -8.76% |
| Return on equity (ttm) | -20.85% |
Income statement
| Revenue (ttm) | 839.53M |
| Revenue per share (ttm) | 0.40 |
| Quarterly revenue growth (yoy) | 41.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -358.52M |
| Net income avi to common (ttm) | -95.48M |
| Diluted EPS (ttm) | -0.350 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.93B |
| Total cash per share (mrq) | 0.91 |
| Total debt (mrq) | 842.5M |
| Total debt/equity (mrq) | 41.21% |
| Current ratio (mrq) | 4.76 |
| Book value per share (mrq) | 0.65 |
Cash flow statement
| Operating cash flow (ttm) | -286.91M |
| Levered free cash flow (ttm) | -594.79M |
© 2024 Yahoo. All rights reserved.